← Back to Search

Behavioural Intervention

CogMed for Opioid Use Disorder

N/A
Waitlist Available
Research Sponsored by New York State Psychiatric Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-month follow up
Awards & highlights

Study Summary

This trial will help researchers understand if there is a relationship between non-fatal opioid overdoses and cognitive functioning, as well as if computerized working memory training can help improve relevant outcomes.

Eligible Conditions
  • Opioid Use Disorder
  • Cognitive Impairment

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
NIH Toolbox Cognition Battery
Secondary outcome measures
Illicit Substance Use: Timeline Follow Back (TLFB)
Impulsive decision making (Delay Discounting Task)
Psychosocial Functioning (Brief Inventory of Psychosocial Functioning B-IPF)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ActiveExperimental Treatment1 Intervention
Working memory training with task-difficulty increasing across sessions
Group II: ShamActive Control1 Intervention
Working memory training with task-difficulty remaining constant across sessions.

Find a Location

Who is running the clinical trial?

New York State Psychiatric InstituteLead Sponsor
475 Previous Clinical Trials
153,871 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there specific demographics who would be more suited to participate in this experiment?

"This research project requires 36 individuals with a history of substance misuse, aged between 18 and 65. Furthermore, these participants must possess good physical health, be enrolled in buprenorphine/naloxone therapy, agree to the contact details of their treatment provider being accessed by the researchers involved in this study, have recently used illicit opioids, and own either a smartphone device or computer."

Answered by AI

Does this research study include participants that are over 30?

"According to the prerequisites for enrolling in this trial, prospective participants must be aged between 18 and 65 years old. There are 104 separate trials that cater specifically to minors while 529 clinical studies accommodate those over the age of 65."

Answered by AI

Is there an active recruitment phase for this investigation?

"Affirmative. Publicly available information on clinicaltrials.gov reveals that this investigation is currently recruiting patients. The study was published in September of 2021, and the newest update came in September 2022; it seeks to enrol 36 people from a single site."

Answered by AI

What is the size of this medical trial's participant cohort?

"Affirmative. The data located on clinicaltrials.gov reveals that recruitment for this research endeavour is underway, beginning from the 21st of September 2021 and last updated on the 29th of September 2022. A total of 36 volunteers are being sought out at a single medical facility."

Answered by AI

Who else is applying?

What state do they live in?
New Jersey
Oregon
How old are they?
18 - 65
What site did they apply to?
NY State Psychiatric Institute
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

Looking for help with my addiction.
PatientReceived no prior treatments
~2 spots leftby Jul 2024